Elevation Oncology, Inc.
NASDAQ:ELEV
0.5942 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 0 | 0.058 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 0.004 | 0.01 | 0.01 | 0.009 | 0.01 | 0.01 | 0.01 | 0.008 | 0.005 | 0.004 | 0.005 | 0.003 | 0.006 | 0.004 | 0 | 0 | 0 | 0 |
| Brutowinst
| -0.004 | -0.01 | 0.048 | -0.009 | -0.01 | -0.01 | -0.01 | -0.008 | -0.005 | -0.004 | -0.005 | -0.003 | -0.006 | -0.004 | 0 | 0 | 0 | 0 |
| Brutowinstmarge
| 0 | 0 | 0.828 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 6.551 | 6.011 | 4.691 | 7.422 | 6.029 | 7.292 | 14.502 | 34.34 | 16.3 | 13.575 | 6.249 | 9.298 | 3.914 | 4.134 | 8.434 | 2.55 | 3.004 | 1.488 |
| Algemene en administratieve kosten
| 4.412 | 3.858 | 3.255 | 3.498 | 3.805 | 4.346 | 4.035 | 4.191 | 3.813 | 3.793 | 3.375 | 2.979 | 1.145 | 0.952 | 0.453 | 0.462 | 0.414 | 0.471 |
| Verkoop- en marketingkosten
| -0.004 | 3.844 | -0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 4.408 | 3.848 | 3.245 | 3.498 | 3.805 | 4.346 | 4.035 | 4.191 | 3.813 | 3.793 | 3.375 | 2.979 | 1.145 | 0.952 | 0.453 | 0.462 | 0.414 | 0.471 |
| Overige kosten
| 0 | 0 | 0.056 | 0.295 | -0.271 | -0.309 | -0.48 | -0.306 | 0.187 | 0.093 | 0.002 | 0.01 | 0 | -0.005 | -0.003 | 0.001 | 0.012 | 0.001 |
| Bedrijfskosten
| 10.959 | 9.859 | 7.936 | 10.92 | 9.834 | 11.638 | 18.537 | 38.531 | 20.113 | 17.368 | 9.624 | 12.277 | 5.059 | 5.086 | 8.887 | 3.012 | 3.418 | 1.959 |
| Bedrijfsresultaat
| -10.963 | -9.869 | -7.946 | -10.92 | -9.834 | -16.745 | -18.537 | -38.531 | -20.113 | -17.368 | -9.624 | -12.277 | -5.059 | -5.086 | -8.887 | -3.012 | -3.418 | -1.959 |
| Bedrijfsresultaat ratio
| 0 | 0 | -137 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 0.513 | -0.827 | 0.056 | 0.295 | -0.271 | -0.309 | -0.48 | -0.306 | 0.187 | 0.093 | 0.002 | 0.01 | 0 | -0.005 | -0.003 | 0.001 | 0.012 | 0.001 |
| Inkomen voor belasting
| -10.45 | -10.696 | -7.89 | -10.625 | -10.105 | -17.054 | -19.017 | -38.837 | -19.926 | -17.275 | -9.622 | -12.267 | -5.059 | -5.091 | -8.89 | -3.011 | -3.406 | -1.958 |
| Inkomen voor belasting ratio
| 0 | 0 | -136.034 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0.011 | 0.011 | 0.009 | 0.011 | 0.005 | 0.005 | 0.025 | 0.306 | -0.187 | -0.093 | 0 | 0 | 0 | 0 | 0 | -3.012 | -3.418 | -1.959 |
| Nettowinst
| -10.461 | -10.707 | -7.899 | -10.636 | -10.11 | -17.059 | -19.042 | -39.143 | -19.739 | -17.182 | -9.622 | -12.267 | -5.059 | -5.091 | -8.89 | -3.011 | -3.406 | -1.958 |
| Nettowinstmarge
| 0 | 0 | -136.19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -0.18 | -0.23 | -0.19 | -0.25 | -0.37 | -0.72 | -0.82 | -1.68 | -0.85 | -0.74 | -0.79 | -0.53 | -4.84 | -0.22 | -0.54 | -0.18 | -0.21 | -0.12 |
| Verwaterde WPA
| -0.18 | -0.23 | -0.19 | -0.25 | -0.37 | -0.72 | -0.82 | -1.68 | -0.85 | -0.74 | -0.79 | -0.53 | -4.84 | -0.22 | -0.54 | -0.18 | -0.21 | -0.12 |
| EBITDA
| -10.959 | -9.859 | -7.936 | -10.92 | -9.824 | -6.521 | -18.537 | -38.523 | -20.108 | -17.364 | -9.619 | -12.274 | -5.053 | -5.082 | -8.872 | -3.012 | -3.418 | -1.959 |
| EBITDA ratio
| 0 | 0 | -136.828 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |